bf/NASDAQ:ADMP_icon.jpeg

NASDAQ:ADMP

Adamis Pharmaceuticals Corporation

  • Stock

0.78

+0.85%

0.01

USD last updated 11/08 02:03:55

Last Close

0.77

07/09 19:59

Market Cap

7.25M

Beta: 1.23

Volume Today

119.48K

Avg: 1.54M

PE Ratio

−0.12

PFCF: −0.54

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic ...Show More

    Earnings

    Earnings per Share (Estimate*)

    -20-1010202016-12-312018-11-092020-05-182021-06-302022-11-28

    Revenue (Estimate*)

    -2M2M4M6M8M10M2016-12-312018-11-092020-05-182021-06-302022-11-28

    *Estimate based on analyst consensus